Alis Biosciences launches fund to free over USD$30 billion of capital trapped in listed development-stage life sciences and biotech companies

Alis Biosciences United Kingdom

Significant market inefficiencies have left over USD$30 billion of capital trapped in c.300 listed biotech companies worldwide that have experienced clinical or regulatory setbacksFund provides efficient mechanism to help investors recoup and recycle trapped cash, while allowing residual science and IP to be developedFund to be listed on public markets in due courseLed by highly experienced industry and investment executives Annalisa Jenkins and Nicholas JohnstonView original content:https://www.prnewswire.co.uk/news-releases/alis-biosciences-launches-fund-to-free-over-usd30-billion-of-capital-trapped-in-listed-development-stage-life-sciences-and-biotech-companies-302431959.html